Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SCN9A | Q15858 | 20/20 | 0.53 |
| ▸ | SCN5A | Q14524 | 4/20 | 0.49 |
| ▸ | SCN1A | P35498 | 2/20 | 0.49 |
| ▸ | SCN2A | Q99250 | 2/20 | 0.49 |
| ▸ | SCN8A | Q9UQD0 | 2/20 | 0.49 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.48 |
| ▸ | SCN7A | Q01118 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29028737 | 0.90 | SCN9A (0.53) | SCN9ASCN5ASCN1ASCN2ASCN8A | |
| SCHEMBL18243861 | 0.89 | SCN9A (0.49) | SCN9ASCN5ASCN1ASCN2ASCN8A | |
| SCHEMBL16770874 | 0.89 | SCN9A (0.59) | SCN9ASCN5ASCN1ASCN2ASCN8A | |
| SCHEMBL16770869 | 0.89 | SCN9A (0.49) | SCN9ASCN5ASCN1ASCN2ASCN8A | |
| Hydrochloric Acid SCHEMBL16759408 | 0.88 | SCN9A (0.58) | SCN9ASCN5ASCN1ASCN2ASCN8A | |
| SCHEMBL18243755 | 0.88 | SCN9A (0.48) | SCN9ASCN5ASCN1ASCN2ASCN8A | |
| SCHEMBL18243763 | 0.88 | SCN9A (0.53) | SCN9ASCN5ASCN1ASCN2ASCN8A | |
| Hydrochloric Acid SCHEMBL16758826 | 0.88 | SCN9A (0.48) | SCN9ASCN5ASCN1ASCN2ASCN8A | |
| Hydrochloric Acid SCHEMBL18263271 | 0.87 | SCN9A (0.52) | SCN9ASCN5ASCN1ASCN2ASCN8A | |
| Hydrochloric Acid SCHEMBL17423323 | 0.87 | SCN9A (0.52) | SCN9ASCN5ASCN1ASCN2ASCN8A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111212830-B | N- (substituted sulfonyl) benzamide derivative and preparation method and medical application thereof | 浙江海正药业股份有限公司 | 2023-07-04 | — | — | CN | disclosed |